Kenneth J. Vega
Chief, Division of Gastroenterology
Division of Gastroenterology
Department of Medicine
America’s Top Doctors 2017 — Castle Connolly Medical, Ltd.
Kenneth Vega, MD, is a gastroenterologist at National Jewish Health. Dr. Vega serves as Chief of the Division of Gastroenterology in the Department of Medicine.

Special Interests

Dr. Vega is the author of more than 55 original articles, reviews and book chapters as well as presented original research at local, regional, national and international scientific meetings. His research focuses on gastrointestinal reflux disease, Barrett’s esophagus, esophageal stem cells, esophageal motility, epidemiology of gastrointestinal cancers along with ethnic/gender disparities in gastrointestinal diseases, treatment and outcome.


Cornell University Medical College, NY, NY, MD
Temple University Hospital, Philadelphia, PA, Gastroenterology
Boston City Hospital, Boston, MA, Medicine

Awards & Recognition

2016: America's Top Doctors: Casthel Connolly Medical, Ltd.
2008: American Society of Gastrointestinal Endoscopy Diversity Award
2008: Amcerican College of Gastroenterology Radhika Srinivasan Gender Based Research Award

Board Certification

1999: Gastroenterology
1995: Medicine

Professional Memberships

2015-2017: Member, American Society of Gastrointestinal Endoscopy
2015-2017: Member, American College of Gastroenterology
2015-2017: President, Arkansas Oklahoma Endoscopy Society
2013: Fellow, American Gastroenterological Association
2012: Fellow, American College of Physicians


Vega KJ, Chisholm S, Jamal MM.  Comparison of reflux esophagitis and its complications between African Americans and non-Hispanic whites.  World J Gastroenterol 2009; 15: 2878-2881.
Khoury JE, Chisholm S, Jamal MM, Palacio C, Pudhota S, Vega KJ.  African Americans with Barrett’s esophagus are less likely to have dysplasia at biopsy.  Dig Dis Sci 2012; 57: 419-423.
Vega KJ, May R, Sureban SM, Lightfoot SA, Qu D, Reed A, Weygant N, Ramanujam R, Souza R, Madhoun M, Whorton J, Anant S, Meltzer S, Houchen CW.  Identification of the putative intestinal stem cell marker doublecortin and CaM kinase-like-1 in Barrett’s esophagus and esophageal adenocarcinoma.  J Gastroenterol Hepatol 2012; 27: 773-780.
Whorton J, Lightfoot S, Sureban SM, May R, Qu D, Madhoun M, Tierney WM, Maple JT, Vega KJ, Houchen CW.  DCLK1 is detectable in plasma of patients with Barrett’s esophagus and esophageal adenocarcinoma.  Dig Dis Sci 2015; 60: 509-513.

Alkaddour A, McGaw C, Hritani R, Palacio C, Nakshabendi R, Munoz JC, Vega KJ. African American ethnicity is not associated with development of Barrett’s esophagus following erosive esophagitis.  Dig Liver Dis 2015; 47: 853-856.

Ask a Question through Patient Portal

Sign in to your My National Jewish Health patient portal account to communicate with your care team, manage appointments, and more. Create an Account

Contact Information

  • Office: 877.225.5654



  • National Jewish Health Main Campus
    1400 Jackson St.
    Denver, CO 80206

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey.


Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.